A protein drug used to be extracted from the organs of slaughtered animals. One batch is withdrawn because it may carry a disease-causing agent from those animals. According to NCERT's summary, which feature of recombinant therapeutics removes this particular problem?
Practice Questions · Question 29 of 30
A protein drug used to be extracted from the organs of slaughtered animals.
(A) They are identical to human proteins, so they do not induce unwanted immunological responses in the patients who receive them.
(B) About 30 of them have been approved for human use the world over, and 12 of these are presently being marketed in India.
- Correct answer
(C) They are free from the risk of infection that was observed with similar products isolated from non-human sources.
(D) Their polypeptide chains are made separately and joined by disulphide bonds, so the product needs no further processing.
Option (C) is correct.
Explanation: NCERT's summary: "Since the recombinant therapeutics are identical to human proteins, they do not induce unwanted immunological responses and are free from risk of infection as was observed in case of similar products isolated from non-human sources." The problem in the question is a possible infection carried over from the animal source, so the relevant feature is freedom from the risk of infection.
- (A) is true, but it deals with immune reactions (such as allergy), not with a disease agent carried in the product.
- (B) is a true fact, but the number of approved products has nothing to do with the safety of a batch.
- (D) describes how Eli Lilly made insulin; it is not a general feature of recombinant therapeutics and has nothing to do with infection.
